Tourmaline Bio, Inc. Files 8-K, Formerly Talaris Therapeutics
| Field | Detail |
|---|---|
| Company | Tourmaline Bio, Inc. |
| Form Type | 8-K |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-history, name-change
TL;DR
Tourmaline Bio (fka Talaris Therapeutics) filed an 8-K on 5/20/25. No new material info, just corporate history.
AI Summary
On May 20, 2025, Tourmaline Bio, Inc. filed an 8-K to disclose other events. The company was formerly known as Talaris Therapeutics, Inc. and changed its name on October 7, 2020. The filing does not contain specific financial details or new material events beyond the name change history.
Why It Matters
This filing serves as a public record of Tourmaline Bio's corporate identity and its previous name, Talaris Therapeutics, which may be relevant for historical tracking and understanding corporate evolution.
Risk Assessment
Risk Level: low — The filing is primarily historical and administrative, with no new financial or operational disclosures that would indicate immediate risk.
Key Players & Entities
- Tourmaline Bio, Inc. (company) — Registrant
- Talaris Therapeutics, Inc. (company) — Former company name
- May 20, 2025 (date) — Date of report
- October 7, 2020 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Tourmaline Bio, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and to provide historical corporate information, including its former name.
When did Tourmaline Bio, Inc. change its name?
Tourmaline Bio, Inc. changed its name on October 7, 2020.
What was Tourmaline Bio, Inc.'s former name?
Tourmaline Bio, Inc.'s former name was Talaris Therapeutics, Inc.
What is the filing date of this 8-K report?
The filing date of this 8-K report is May 20, 2025.
Does this filing disclose any new financial results or material business developments?
Based on the provided text, this filing does not appear to disclose new financial results or material business developments; it primarily serves as a historical corporate record update.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Tourmaline Bio, Inc..